FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972412925> ?p ?o ?g. }

• W1972412925 endingPage "703" @default.
• W1972412925 startingPage "703" @default.
• W1972412925 abstract "Quality Indicators for Assessing Care of Vulnerable Elders16 October 2001Quality Indicators for Appropriate Medication Use in Vulnerable EldersEric L. Knight, MD, MPH and Jerry Avorn, MDEric L. Knight, MD, MPHFrom Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.Search for more papers by this author and Jerry Avorn, MDFrom Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-8_Part_2-200110161-00009 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Medications are a centrally important aspect of the care of elderly patients, especially vulnerable elders, and are the final common pathway for most therapeutic decisions. While they make up only 14% of the U.S. population, persons 65 years of age and older consume more than 30% of all prescription drugs (1). Because they more often experience acute and chronic illnesses, elders are particularly likely to benefit from the therapeutic and preventive effects of pharmaceutical therapy. However, aspects of the aging process that occur in healthy elders and that are considerably magnified in vulnerable elderly patients increase their risk for drug ...References 1. Chrischilles EA, Foley DJ, Wallace RB, Lemke JH, Semla TP, Hanlon JT, et al . Use of medications by persons 65 and over: data from the established populations for epidemiologic studies of the elderly. J Gerontol. 1992;47:M137-44. [PMID: 1512428] CrossrefMedlineGoogle Scholar 2. Avorn J, Gurwitz JH, Rochon P. Geriatric Medicine. 4th ed. New York: Springer-Verlag; 2001. Google Scholar 3. Shekelle PG, MacLean CH, Morton SC, Wenger NS. Assessing care of vulnerable elders: methods for developing quality indicators. Ann Intern Med. 2001;135:647-52. LinkGoogle Scholar 4. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-61. [PMID: 9708588] CrossrefMedlineGoogle Scholar 5. González-Fernández RA, Rivera M, Torres D, Quiles J, Jackson A. Usefulness of a systemic hypertension in-hospital educational program. Am J Cardiol. 1990;65:1384-6. [PMID: 2188495] CrossrefMedlineGoogle Scholar 6. Lowe CJ, Raynor DK, Courtney EA, Purvis J, Teale C. Effects of self medication programme on knowledge of drugs and compliance with treatment in elderly patients. BMJ. 1995;310:1229-31. [PMID: 7767193] CrossrefMedlineGoogle Scholar 7. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270-6. [PMID: 8873488] CrossrefMedlineGoogle Scholar 8. Goodyer LI, Miskelly F, Milligan P. Does encouraging good compliance improve patients' clinical condition in heart failure? Br J Clin Pract. 1995;49:173-6. [PMID: 7547154] MedlineGoogle Scholar 9. Monane M, Matthias DM, Nagle BA, Kelly MA. Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA. 1998;280:1249-52. [PMID: 9786375] CrossrefMedlineGoogle Scholar 10. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al . Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA. 1997;277:739-45. [PMID: 9042847] CrossrefMedlineGoogle Scholar 11. . Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA. 1991;265:3255-64. [PMID: 2046107] CrossrefMedlineGoogle Scholar 12. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhäger WH, et al . Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997;350:757-64. [PMID: 9297994] CrossrefMedlineGoogle Scholar 13. . The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-46. [PMID: 9385294] CrossrefMedlineGoogle Scholar 14. Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825-32. [PMID: 1888249] CrossrefMedlineGoogle Scholar 15. Willcox SM, Himmelstein DU, Woolhandler S. Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292-6. [PMID: 8028142] CrossrefMedlineGoogle Scholar 16. Beers MH, Ouslander JG, Fingold SF, Morgenstern H, Reuben DB, Rogers W, et al . Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684-9. [PMID: 1308759] LinkGoogle Scholar 17. Hanlon JT, Weinberger M, Samsa GP, Schmader KE, Uttech KM, Lewis IK, et al . A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996;100:428-37. [PMID: 8610730] CrossrefMedlineGoogle Scholar 18. Evaluation of drug use review demonstration projects. Contract no.: 500-93-0002. Cambridge, MA: Abt Associates; 1998. Google Scholar 19. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al . Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 1998;114:445S-469S. [PMID: 9822057] CrossrefMedlineGoogle Scholar 20. Chiquette E, Amato MG, Bussey HI. Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs. Arch Intern Med. 1998;158:1641-7. [PMID: 9701098] CrossrefMedlineGoogle Scholar 21. Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996;335:540-6. [PMID: 8678931] CrossrefMedlineGoogle Scholar 22. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med. 1994;120:897-902. [PMID: 8172435] LinkGoogle Scholar 23. Hirsh J. Optimal intensity and monitoring warfarin. Am J Cardiol. 1995;75:39B-42B. [PMID: 7863972] CrossrefMedlineGoogle Scholar 24. Siegel D, Hulley SB, Black DM, Cheitlin MD, Sebastian A, Seeley DG, et al . Diuretics, serum and intracellular electrolyte levels, and ventricular arrhythmias in hypertensive men. JAMA. 1992;267:1083-9. [PMID: 1735925] CrossrefMedlineGoogle Scholar 25. Siscovick DS, Raghunathan TE, Psaty BM, Koepsell TD, Wicklund KG, Lin X, et al . Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med. 1994;330:1852-7. [PMID: 8196728] CrossrefMedlineGoogle Scholar 26. Ferner RE, Neil HA. Sulphonylureas and hypoglycaemia. Br Med J (Clin Res Ed). 1988;296:949-50. [PMID: 3129103] CrossrefMedlineGoogle Scholar 27. Seltzer HS. Drug-induced hypoglycemia. A review based on 473 cases. Diabetes. 1972;21:955-66. [PMID: 4626706] CrossrefMedlineGoogle Scholar 28. Paice BJ, Paterson KR, Lawson DH. Undesired effects of the sulphonylurea drugs. Adverse Drug React Acute Poisoning Rev. 1985;4:23-36. [PMID: 3890480] MedlineGoogle Scholar 29. Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia. 1983;24:412-7. [PMID: 6411511] CrossrefMedlineGoogle Scholar 30. Potamianos G, Kellett JM. Anti-cholinergic drugs and memory: the effects of benzhexol on memory in a group of geriatric patients. Br J Psychiatry. 1982;140:470-2. [PMID: 7049291] CrossrefMedlineGoogle Scholar 31. Goetz DW, Jacobson JM, Murnane JE, Reid MJ, Repperger DW, Goodyear C, et al . Prolongation of simple and choice reaction times in a double-blind comparison of twice-daily hydroxyzine versus terfenadine. J Allergy Clin Immunol. 1989;84:316-22. [PMID: 2570798] CrossrefMedlineGoogle Scholar 32. Sands L, Katz IR, DiFilippo S, D'Angelo K, Boyce A, Cooper T. Identification of drug-related cognitive impairment in older individuals. Challenge studies with diphenhydramine. Am J Geriatr Psychiatry. 1997;5:156-66. [PMID: 9106379] MedlineGoogle Scholar 33. Simons FE, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med. 1994;330:1663-70. [PMID: 7909915] CrossrefMedlineGoogle Scholar 34. Appell RA. Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis. Urology. 1997;50:90-6; discussion 97-9. [PMID: 9426760] CrossrefMedlineGoogle Scholar 35. Abrams P, Freeman R, Anderström C, Mattiasson A. Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br J Urol. 1998;81:801-10. [PMID: 9666761] CrossrefMedlineGoogle Scholar 36. Monane M, Avorn J, Beers MH, Everitt DE. Anticholinergic drug use and bowel function in nursing home patients. Arch Intern Med. 1993;153:633-8. [PMID: 8439226] CrossrefMedlineGoogle Scholar 37. Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O'Brien LA, et al . Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med. 1991;324:1326-31. [PMID: 2017229] CrossrefMedlineGoogle Scholar 38. MacDonald JB, MacDonald ET. Nocturnal femoral fracture and continuing widespread use of barbiturate hypnotics. Br Med J. 1977;2:483-5. [PMID: 890361] CrossrefMedlineGoogle Scholar 39. Eisendrath SJ, Goldman B, Douglas J, Dimatteo L, Van Dyke C. Meperidine-induced delirium. Am J Psychiatry. 1987;144:1062-5. [PMID: 3605428] CrossrefMedlineGoogle Scholar 40. Marcantonio ER, Juarez G, Goldman L, Mangione CM, Ludwig LE, Lind L, et al . The relationship of postoperative delirium with psychoactive medications. JAMA. 1994;272:1518-22. [PMID: 7966844] CrossrefMedlineGoogle Scholar 41. Koenig KL, Hodgson L, Kozak R, Jordan K, Sexton TR, Leiken AM. Ketorolac vs meperidine for the management of pain in the emergency department. Acad Emerg Med. 1994;1:544-9. [PMID: 7600401] CrossrefMedlineGoogle Scholar 42. MacDowall P, Kalra PA, O'Donoghue DJ, Waldek S, Mamtora H, Brown K. Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure. Lancet. 1998;352:13-6. [PMID: 9800739] CrossrefMedlineGoogle Scholar 43. Knight EL, Glynn RJ, McIntyre KM, Mogun H, Avorn J. Predictors of decreased renal function in patients with heart failure during angiotensin-converting enzyme inhibitor therapy: results from the studies of left ventricular dysfunction (SOLVD). Am Heart J. 1999;138:849-55. [PMID: 10539815] CrossrefMedlineGoogle Scholar 44. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med. 1998;158:26-32. [PMID: 9437375] CrossrefMedlineGoogle Scholar 45. Kalra PA, Kumwenda M, MacDowall P, Roland MO. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure. BMJ. 1999;318:234-7. [PMID: 9915733] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.Grant Support: By a contract from Pfizer Inc. to RAND.Corresponding Author: Jerry Avorn, MD, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115.Current Author Addresses: Dr. Knight: Channing Laboratory, 181 Longwood Avenue, Boston, MA 02115.Dr. Avorn: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 221 Longwood Avenue, Boston, MA 02115. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoACOVE Quality Indicators Metrics Cited ByNo impact of a prescription booklet on medication consumption in nursing home residents from 2011 to 2014: a controlled before–after studyMedication taking in a national sample of dependent older peopleThe OptimaMed intervention to reduce inappropriate medications in nursing home residents with severe dementia: results from a quasi-experimental feasibility pilot studyIndicators for assessing quality of drug use: A systematic literature reviewUse of Preventive Medication in Patients With Limited Life Expectancy: A Systematic ReviewBuilding quality indicators for medication use in people aging with intellectual disabilities and behaviour disordersEffect evaluation of an interprofessional medication therapy management approach for multimorbid patients in primary care: a cluster-randomized controlled trial in community care (WestGem study protocol)Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful InterventionMethods to control the pharmaceutical cost impact of chronic conditions in the elderlyFactors predicting home storage of medicines in Northern UgandaInterventions to improve the appropriate use of polypharmacy for older peoplePotentially Inappropriate Medications in Community-Dwelling Older AdultsAppropriate prescribing in older peopleMedication Reviews by Clinical Pharmacists at Hospitals Lead to Improved Patient Outcomes: A Systematic ReviewA practical guide to monitoring for adverse drug reactions during antihypertensive drug therapyAnticholinergic Burden: Clinical Implications for Seniors and Strategies for CliniciansHyperkalemia Associated with Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor BlockersInterventions to improve the appropriate use of polypharmacy for older peopleInappropriate Drug Prescription at Nursing Home AdmissionClinical quality indicators in laboratory medicineRacial Disparities in Quality of Medication Use in Older Adults: Findings From a Longitudinal StudyDesign Lessons for Older Adult Personal Health Records Software from Older AdultsRetrospective Evaluation of Home Medicines Review by Pharmacists in Older Australian Patients Using the Medication Appropriateness IndexSeguimiento del paciente anciano polimedicado en un área de saludCommunity Physician Education in Geriatrics: Applying the Assessing Care of Vulnerable Elders Model with a Multisite Primary Care GroupArzneimittelinteraktionenDiabetes and Drug-Associated Hyperkalemia: Effect of Potassium MonitoringRacial Disparities in the Quality of Medication Use in Older Adults: Baseline Findings from a Longitudinal StudyMonitoring polymedicated elderly patients in a health care unitArzneimitteltherapie im AlterMethodology of a pilot study to improve the quality of medication use in older adults: Enhancing quality in psychiatry using pharmacists (EQUIPP)Impact of Interpreters on the Receipt of New Prescription Medication Information Among Spanish-Speaking LatinosMagnitude of potentially inappropriate prescribing in Germany among older patients with generalized anxiety disorderInterventions to improve the appropriate use of polypharmacy for older peopleImplications and Management of Decline for the Elderly PatientWhich Providers Should Communicate Which Critical Information About a New Medication? Patient, Pharmacist, and Physician PerspectivesRational Prescribing for Patients With a Reduced Life ExpectancyThe quality of medication use in older adults: Methods of a longitudinal studyThe Iowa Continuity of Care study: Background and methodsHow much time does it take to prescribe a new medication?Prevención de la dependencia en las personas mayoresMethodology of an ongoing, randomized controlled trial to prevent falls through enhanced pharmaceutical carePromoting Safer Medication Use Among Older AdultsGeropharmacologyOver-The-Counter Medication Use in Older AdultsLa douleur aiguë chez le sujet âgé aux UrgencesClinical Pharmacy Services in the HomePrevención de la dependencia en las personas mayoresQuality of Clinical Documentation and Anticoagulation Control in Patients With Chronic Nonvalvular Atrial Fibrillation in Routine Medical CareThe Safety of Warfarin Therapy in the Nursing Home SettingAppropriate prescribing in older peopleAssociation of specialist involvement and quality of care for Parkinson's diseaseMedication errors in older adults: A review of recent publicationsDoes Ambulatory Process of Care Predict Health-Related Quality of Life Outcomes for Patients with Chronic Disease?Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockersInitial AssessmentDeliriumPolypharmacy and potential inappropriateness of pharmaco-logical treatment among commuinity-dwellling elderly patientsFactor analysis improves the selection of prescribing indicatorsClinically important drug-disease interactions and their prevalence in older adultsPrescribing to older ED patientsImproving Medication Management for Older Adult ClientsElderly patients need ongoing assessment and support to avoid risk of medication-related problemsIdentification of Potential Drug-related Problems in the Elderly: The Role of the Community PharmacistPrescription médicamenteuse du sujet âgéPrise en charge des cancers colorectaux des sujets âgésFactors associated with potentially inappropriate drug utilization in a sample of rural community-dwelling older adultsInappropriate drug prescribing in older adults: the updated 2002 Beers criteria - a population-based cohort studyWarfarin Monitoring in Ambulatory Older Individuals Receiving Antimicrobial TherapyPrescription médicamenteuse du sujet âgéA review of uses of health care utilization databases for epidemiologic research on therapeuticsPrescripción de medicamentos en la persona de edad avanzadaMedication-Related Problems in the ElderlyMedical speciality and pattern of medicines prescriptionInfluence of socioeconomic status on the quality of prescribing in the elderly - a population based studyPopulation-Based Medication Reviews: A Descriptive Analysis of the Medication Issues Identified in a Medicare Not-for-Profit Prescription Discount ProgramUpdate on drug-related problems in the elderlyUse of potentially inappropriate pain-related medications in older adults with painful neuropathic disordersAppropriate prescribing for older people: managing the effects of ageingGeriatric rehabilitation. 2. Physiatric approach to the older adult1∗1No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the authors(s) or upon any organization with which the author(s) is/are associated.∗Key referencesImpact of inappropriate drug use on health services utilization among representative older community-dwelling residentsThe Quality of Medical Care Provided to Vulnerable Older Patients with Chronic PainEffects of geriatric evaluation and management on adverse drug reactions and suboptimal prescribing in the frail elderlyPotentially Inappropriate Antiepileptic Drugs for Elderly Patients with EpilepsyPharmacological Issues in the Very Old: The Treatment of Heart DiseaseThe Role of Pharmacoepidemiology and Pharmacoeconomics in Promoting Access and Stimulating InnovationImproving Medication Use for Older Adults: An Integrated Research AgendaMichael D. Murray, MPH, PharmD and Christopher M. Callahan, MDUpdate on drug-related problems in the elderlyPrescribing Indicators for Evaluating Drug Use in Nursing HomesComposition and Cost of Drugs Stored at Home by Elderly PatientsBringing epidemiology into drug utilisation researchDevelopment of a list of consensus-approved clinical indicators of preventable drug-related morbidity in older adultsAnticholinergics: The good and the badKwaliteitsindicatoren prescriptie aan ouderenMedication misadventure in cancer careCurrent AwarenessBalancing the Cost and Value of Medications 16 October 2001Volume 135, Issue 8_Part_2Page: 703-710KeywordsAdverse reactionsCaregiversDrug interactionsDrug therapyDrugsElderlyHypertensionInternational normalized ratioPotassiumQuality indicators ePublished: 16 October 2001 Issue Published: 16 October 2001 CopyrightCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ..." @default.
• W1972412925 created "2016-06-24" @default.
• W1972412925 creator A5063035844 @default.
• W1972412925 date "2001-10-16" @default.
• W1972412925 modified "2023-10-03" @default.
• W1972412925 title "Quality Indicators for Appropriate Medication Use in Vulnerable Elders" @default.
• W1972412925 cites W1571399346 @default.
• W1972412925 cites W1963662587 @default.
• W1972412925 cites W1965794340 @default.
• W1972412925 cites W1970083430 @default.
• W1972412925 cites W1971045763 @default.
• W1972412925 cites W1972565234 @default.
• W1972412925 cites W1982775223 @default.
• W1972412925 cites W1984154610 @default.
• W1972412925 cites W1984458266 @default.
• W1972412925 cites W1989252935 @default.
• W1972412925 cites W2012114534 @default.
• W1972412925 cites W2015959379 @default.
• W1972412925 cites W2019839635 @default.
• W1972412925 cites W2024975356 @default.
• W1972412925 cites W2025970694 @default.
• W1972412925 cites W2041131399 @default.
• W1972412925 cites W2048424589 @default.
• W1972412925 cites W2051017123 @default.
• W1972412925 cites W2055825639 @default.
• W1972412925 cites W2061436427 @default.
• W1972412925 cites W2064590051 @default.
• W1972412925 cites W2064836413 @default.
• W1972412925 cites W2068868940 @default.
• W1972412925 cites W2079295837 @default.
• W1972412925 cites W2081146355 @default.
• W1972412925 cites W2081740683 @default.
• W1972412925 cites W2088679190 @default.
• W1972412925 cites W2089141101 @default.
• W1972412925 cites W2114634962 @default.
• W1972412925 cites W2118746357 @default.
• W1972412925 cites W2125650394 @default.
• W1972412925 cites W2170931442 @default.
• W1972412925 cites W2171651768 @default.
• W1972412925 cites W2312673624 @default.
• W1972412925 cites W2313064083 @default.
• W1972412925 cites W2329387762 @default.
• W1972412925 cites W2335554724 @default.
• W1972412925 cites W2340635798 @default.
• W1972412925 cites W2395386213 @default.
• W1972412925 cites W2414167269 @default.
• W1972412925 cites W2472631516 @default.
• W1972412925 cites W87070752 @default.
• W1972412925 cites W1996830682 @default.
• W1972412925 doi "https://doi.org/10.7326/0003-4819-135-8_part_2-200110161-00009" @default.
• W1972412925 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11601953" @default.
• W1972412925 hasPublicationYear "2001" @default.
• W1972412925 type Work @default.
• W1972412925 sameAs 1972412925 @default.
• W1972412925 citedByCount "139" @default.
• W1972412925 countsByYear W19724129252012 @default.
• W1972412925 countsByYear W19724129252013 @default.
• W1972412925 countsByYear W19724129252014 @default.
• W1972412925 countsByYear W19724129252015 @default.
• W1972412925 countsByYear W19724129252016 @default.
• W1972412925 countsByYear W19724129252017 @default.
• W1972412925 countsByYear W19724129252018 @default.
• W1972412925 countsByYear W19724129252019 @default.
• W1972412925 countsByYear W19724129252020 @default.
• W1972412925 countsByYear W19724129252021 @default.
• W1972412925 countsByYear W19724129252022 @default.
• W1972412925 countsByYear W19724129252023 @default.
• W1972412925 crossrefType "journal-article" @default.
• W1972412925 hasAuthorship W1972412925A5063035844 @default.
• W1972412925 hasConcept C111472728 @default.
• W1972412925 hasConcept C138885662 @default.
• W1972412925 hasConcept C160735492 @default.
• W1972412925 hasConcept C162324750 @default.
• W1972412925 hasConcept C177713679 @default.
• W1972412925 hasConcept C2779530757 @default.
• W1972412925 hasConcept C2780131953 @default.
• W1972412925 hasConcept C50522688 @default.
• W1972412925 hasConcept C71924100 @default.
• W1972412925 hasConcept C74909509 @default.
• W1972412925 hasConcept C99454951 @default.
• W1972412925 hasConceptScore W1972412925C111472728 @default.
• W1972412925 hasConceptScore W1972412925C138885662 @default.
• W1972412925 hasConceptScore W1972412925C160735492 @default.
• W1972412925 hasConceptScore W1972412925C162324750 @default.
• W1972412925 hasConceptScore W1972412925C177713679 @default.
• W1972412925 hasConceptScore W1972412925C2779530757 @default.
• W1972412925 hasConceptScore W1972412925C2780131953 @default.
• W1972412925 hasConceptScore W1972412925C50522688 @default.
• W1972412925 hasConceptScore W1972412925C71924100 @default.
• W1972412925 hasConceptScore W1972412925C74909509 @default.
• W1972412925 hasConceptScore W1972412925C99454951 @default.
• W1972412925 hasIssue "8_Part_2" @default.
• W1972412925 hasLocation W19724129251 @default.
• W1972412925 hasLocation W19724129252 @default.
• W1972412925 hasOpenAccess W1972412925 @default.
• W1972412925 hasPrimaryLocation W19724129251 @default.
• W1972412925 hasRelatedWork W1527124137 @default.
• W1972412925 hasRelatedWork W1999881602 @default.

• next